HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hull, J H K Articles by Modarres-Sadeghi, H Search for Related Content PubMed PubMed Citation Articles by Hull, J H K Articles by Modarres-Sadeghi, H Related Collections Drugs: immunological products and vaccines Neuromuscular disease

Severe vasculitic neuropathy following influenza vaccination

¹ Delek Tibetan Hospital, Dharamsala, India
² National Hospital for Neurology and Neurosurgery, Queen Square, London WC1, UK
³ St George’s Hospital, Blackshaw Road, London SW17, UK

Correspondence to:
Correspondence to:
Dr J H K Hull
jiminio@doctors.org.uk

Keywords: influenza vaccination; vasculitic neuropathy

The first 150 words of the full text of this article appear below.

Current Department of Health (UK) guidelines suggest that all people aged over 65 years should receive annual influenza vaccination. There is a range of adverse medical sequelae associated with this. Two serious complications are Guillain-Barré syndrome¹ and systemic vasculitis.^2,3 The strength of association between influenza vaccination and Guillain-Barré syndrome has been questioned, and little is known of the pathogenesis.³ Several investigators have reported a close temporal association between influenza vaccination and systemic vasculitis of various classifications.^2,3 Vasculitic peripheral neuropathy was not a feature in any of the reported cases.^2,3

We report a case of biopsy proven vasculitis, presenting as mononeuritis multiplex, following influenza vaccination. The clinical picture evolved rapidly into a syndrome indistinguishable from axonal Guillain-Barré syndrome. This suggests a differential diagnosis for post-vaccination neuropathy, with implications for management. We believe this is the first report in which there was an associated peripheral neuropathy at presentation. It raises issues about . . . [Full text of this article]